Name: CBIO Balance Sheet - Crescent Biopharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CBIO - Crescent Biopharma, Inc.

USD | NASDAQ | Healthcare

CBIO Balance Sheet - Crescent Biopharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Cash And Short Term Investments
Cash And Equivalents	213.2	34.8	41.8	47.9	90.3	137.0	158.2	209.9	123.9	40.0	46.8	55.2	2.3	17.4	28.2
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	213.2	34.8	41.8	47.9	90.3	137.0	158.2	209.9	123.9	40.0	46.8	55.2	2.3	17.4	28.2
Receivables
Accounts Receivable	18.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	2.6	2.7	2.8	2.7	2.5	2.4	2.1	1.4	1.4	1.2	-
Current Liabilities
Accounts Payable	-	0.3	0.9	1.0	2.1	2.1	1.4	2.7	2.6	1.6	0.6	0.9	1.1	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	189.2	213.2	133.3	-	22.4	-	14.4	22.4	31.3	41.8	49.4	58.0	65.0	47.9	51.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	6.4	5.5	1.3	1.6	0.4	-	1.3	1.5	2.0	2.0	2.6	2.3	3.1	2.8	2.2	1.0	0.9	0.5
Other Current Assets	6.4	5.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	195.6	236.7	134.6	154.2	6.0	-	15.6	23.9	33.3	43.8	52.0	60.4	68.1	50.7	53.8	61.3

Current Liabilities
Accounts Payable	-	-	-	-	0.1	-	0.6	1.0	0.8	0.9	0.3	0.2	0.5	1.0	0.9	1.3	2.3	2.1	1.4	1.2	2.1	2.1	1.1	1.4	3.1	1.4	1.4	3.0	1.9	2.7	0.7	3.2	3.9	2.6	1.6	0.6	0.5	1.6	1.2	1.4
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	3.1	4.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.5	0.4	0.4	0.2	-	-	0.3	0.4	0.6	0.7	0.7	0.8	0.7	0.9	1.1	1.1
Accrued Expenses	4.4	16.3	9.0	7.6	2.5	-	3.5	3.0	3.9	5.2	5.3	5.5	5.6	7.0	5.8	6.6	9.5	8.7
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	14.2	36.1	20.3	16.7	2.6	-	4.3	4.4	5.3	6.8	6.4	6.6	6.7	8.9	7.7	8.9

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	1.1	1.2	1.3	1.4	-	-	-	-	-	0.1	0.3	0.4	-	-	0.1	0.4
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	15.3	37.3	21.6	18.2	2.6	-	4.3	4.4	5.3	6.9	6.7	7.0	6.7	8.9	7.8	9.3

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.1	-	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	374.9	370.8	192.0	190.0	500.0	-	498.5	497.3	496.1	494.8	493.9	492.9	492.1	462.5	457.4	456.5	455.5
Retained Earnings	(195.1)	(171.8)	(79.4)	(54.8)	(496.7)	-	(487.1)	(477.3)	(467.2)	(456.5)	(447.4)	(438.2)	(429.9)	(419.6)	(409.3)	(400.8)	(387.6)
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	183.8	203.0	116.6	139.3	(30.2)	0.0	(1.3)	20.1	28.9	38.4	46.5	54.8	62.2	42.9	48.1	55.7	68.0
Total Equity	183.8	203.0	116.6	139.3	(30.2)	0.0	(1.3)	20.1	28.9	38.4	46.5	54.8	62.2	42.9	48.1	55.7	68.0	81.6

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	181.4	200.6	114.3	137.5	3.4	-	11.3	19.5	28.0	37.0	45.6	53.8	61.3	41.8	46.1	52.3	64.7	79.0
Book Value	183.8	203.0	116.6	139.3	(30.2)	0.0	(1.3)	20.1	28.9	38.4	46.5	54.8	62.2	42.9	48.1	55.7	68.0	81.6
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	2.6	2.6	2.6	2.6	2.6	2.6	2.7	2.7	2.7	2.7	2.7	2.8	2.7	2.7	2.7	2.7	2.7	2.7	2.6	2.5	2.5	2.5	2.4	2.4	2.4	2.3	2.2	2.1	1.7	1.5
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	2.5	2.5	2.4	2.4	2.3	2.3	2.4
Property,Plant & Equipment Net	0.9	0.8	0.8	0.2	-	-	-	-	-	-	0.1	0.2	0.2	0.2	0.3	0.3	0.4
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	1.4	1.5	1.6	1.6	-	-	-	0.4	0.6	0.8	1.0	1.2	0.5	0.8	1.0	1.2
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	1.2	1.2	1.3	1.3	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	199.1	240.3	138.3	157.4	6.0	-	15.7	24.4	34.2	45.3	53.2	61.8	68.9	51.8	56.0	65.0	81.5